New Biologic Drug Is Targeted Treatment for Ovarian Cancer

Researchers have announced the development of a new biologic drug targeted to treat ovarian cancer. Scientists from the Women & Infants Hospital of Rhode Island have created a biologic drug that can halt the manufacture of a protein called HE4 that is present in women who suffer from ovarian cancer. According to ScienceDaily, this protein promotes the aggressive growth of ovarian cancer cells that are also resistant to treatment with chemotherapy. There are three main kinds of ovarian tumors, says the American Cancer Society.